# Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer

> **NCT04903782** · — · RECRUITING · sponsor: **Sydney Children's Hospitals Network** · enrollment: 270 (estimated)

## Conditions studied

- Neoplastic Syndromes, Hereditary
- Cancer
- Genetic Predisposition to Disease

## Interventions

- **DIAGNOSTIC_TEST:** Family-based whole genome sequencing

## Key facts

- **NCT ID:** NCT04903782
- **Lead sponsor:** Sydney Children's Hospitals Network
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-08
- **Primary completion:** 2023-03-08
- **Final completion:** 2028-06-15
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2022-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903782, "Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04903782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*